EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte Studie

Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris

Jan Holmback, Anders Carlsson, Puneet Rinwa

Journal of Drugs in Dermatology · 2023

DOI: 10.36849/jdd.7151 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Drugs in Dermatology, 2023. Written by Jan Holmback and 2 co-authors. Major MEDLINE topics: Dermatologic Agents, Psoriasis, Drug-Related Side Effects and Adverse Reactions.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Calcipotriol, a vitamin D analogue is widely used in the treatment of psoriasis. However, poor adherence to topical therapy has led to an ineffective use of the medication and built a barrier to the treatment's success. A water-free lipid-based formulation system has been developed to improve dosage and cosmetic properties along with patient compliance. This study was conducted to evaluate the efficacy and cutaneous safety of water-free lipid-based formulations containing calcipotriol (50 μg/g) as compared to their corresponding vehicles and marketed calcipotriol formulations in a psoriasis plaque test. In total, 24 subjects with chronic psoriasis vulgaris were enrolled in this single-center, randomized, vehicle, and comparator-controlled clinical trial and treated once daily over a 12-day period (10 applications). The anti-psoriatic effect was evaluated by sonographic measurement of psoriatic infiltrate and investigators' clinical efficacy assessments. The mean reduction in psoriatic infiltrate from baseline to day 12 (end of trial) with lipid-based calcipotriol formulations (-34% and -37%) was statistically significant (P

Subjects

MeSH terms (MEDLINE)

Dermatologic AgentsPsoriasisDrug-Related Side Effects and Adverse ReactionsHumansOintmentsTreatment OutcomeCalcitriolEmollients

Substances

calcipotrieneDermatologic AgentsOintmentsCalcitriolEmollients

Cite

APA

Holmback, J., Carlsson, A., & Rinwa, P. (2023). Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7151

Vancouver

Holmback J, Carlsson A, Rinwa P. Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7151

BibTeX
@article{Holmback2023,
  author = {Holmback, Jan and Carlsson, Anders and Rinwa, Puneet},
  title = {Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris},
  journal = {Journal of Drugs in Dermatology},
  year = {2023},
  doi = {10.36849/jdd.7151}
}
Start for free →